Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · IEX Real-Time Price · USD
6.22
-0.30 (-4.60%)
At close: Jul 2, 2024, 4:00 PM
6.39
+0.17 (2.73%)
After-hours: Jul 2, 2024, 7:31 PM EDT
Ironwood Pharmaceuticals Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for IRWD stock have an average target of 17.75, with a low estimate of 14 and a high estimate of 22. The average target predicts an increase of 185.37% from the current stock price of 6.22.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 10, 2024.
Analyst Ratings
The average analyst rating for IRWD stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $18 → $14 | Strong Buy | Maintains | $18 → $14 | +125.08% | May 10, 2024 |
| Wells Fargo | Wells Fargo | Buy Maintains $20 → $14 | Buy | Maintains | $20 → $14 | +125.08% | Mar 1, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $20 → $21 | Buy | Maintains | $20 → $21 | +237.62% | Feb 16, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +237.62% | Jan 17, 2024 |
| Wells Fargo | Wells Fargo | Buy Initiates $20 | Buy | Initiates | $20 | +221.54% | Dec 14, 2023 |
Financial Forecast
Revenue This Year
418.25M
from 442.74M
Decreased by -5.53%
Revenue Next Year
473.79M
from 418.25M
Increased by 13.28%
EPS This Year
0.51
from -6.45
EPS Next Year
0.75
from 0.51
Increased by 47.67%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 440.9M | 521.2M | 698.7M | 909.3M | 844.2M |
| Avg | 418.3M | 473.8M | 558.3M | 707.2M | 734.4M |
| Low | 394.5M | 424.3M | 460.6M | 520.4M | 623.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.4% | 24.6% | 47.5% | 62.9% | 19.4% |
| Avg | -5.5% | 13.3% | 17.8% | 26.7% | 3.8% |
| Low | -10.9% | 1.5% | -2.8% | -6.8% | -11.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.88 | 1.03 | 1.75 | 2.71 | 2.35 |
| Avg | 0.51 | 0.75 | 1.16 | 1.86 | 1.89 |
| Low | 0.33 | 0.47 | 0.65 | 1.01 | 1.44 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 101.8% | 132.8% | 133.0% | 26.7% |
| Avg | - | 47.7% | 54.4% | 59.6% | 1.9% |
| Low | - | -7.8% | -14.1% | -13.2% | -22.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.